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Hemozoin-catalyzed precipitation polymerization
as an assay for malaria diagnosis
Omar Rifaie-Graham1, Jonas Pollard 1, Samuel Raccio 1, Sandor Balog 1, Sebastian Rusch2,3,
María Andrea Hernández-Castañeda4, Pierre-Yves Mantel4, Hans-Peter Beck 2,3 & Nico Bruns 1
Methods to diagnose malaria are of paramount interest to eradicate the disease. Current
methods have severe limitations, as they are either costly or not sensitive enough to detect
low levels of parasitemia. Here we report an ultrasensitive, yet low-resource chemical assay
for the detection and quantiﬁcation of hemozoin, a biomarker of all Plasmodium species.
Solubilized hemozoin catalyzes the atom transfer radical polymerization of N-iso-
propylacrylamide above the lower critical solution temperature of poly(N-iso-
propylacrylamide). The solution becomes turbid, which can be observed by naked eye and
quantiﬁed by UV-visible spectroscopy. The rate of turbidity increase is proportional to the
concentration of hemozoin, with a detection limit of 0.85 ngmL−1. Malaria parasites in
human blood can be detected down to 10 infected red blood cells μL−1. The assay could
potentially be applied as a point-of-care test. The signal-ampliﬁcation of an analyte by bio-
catalytic precipitation polymerization represents a powerful approach in biosensing.
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Malaria is a common and life-threatening parasitic diseasecaused by several Plasmodium species that is transmittedvia mosquito bites. In 2017, the WHO (World Health
Organization) estimated 3.1 billion people at risk of being infected
by malaria, with 1.1 billion people at high risk. 219 million cases, an
increase of 3 million cases over the previous year, were reported
ending in 435,000 deaths1. Africa remained as the region with the
highest mortality burden accounting for 93% of the deaths. Sixty-
one percent of the worldwide deaths were children under the age of
ﬁve. Detection of malaria infections is one of the keys to eradication
of the disease. For example, highly sensitive techniques to screen
populations in endemic areas are needed to detect and subsequently
treat asymptomatic individuals with submicroscopic Plasmodium
sp. infections who do not display symptoms, but who represent a
major reservoir for the transmission of the disease2,3. An effective
ﬁeld test for malaria must be highly sensitive, its reagents have to be
robust to withstand transport and storage in tropical regions, it has
to be easy to use and should be of low cost. Today, no single malaria
ﬁeld test on the market fulﬁlls all these criteria. Microscopy in
combination with Giemsa staining is the most widely used tech-
nique to diagnose malaria4. It allows the identiﬁcation of the
malaria species and has a detection threshold of ~50 infected red
blood cells (iRBC) µL−1 5. However, this method requires well-
trained microscopists to correctly identify the parasite in a blood
smear. As a result, this diagnosis is mostly performed at central
laboratories or hospitals. This is the reason why malaria rapid
diagnostic tests (MRDTs) were developed for ﬁeld use. Since the
WHO recommended in 2010 the diagnosis of all suspected cases,
the number of people using MRDTs has increased from <200,000
in 2005 to more than 314 million in 20146,7. There are more than
200 MRDTs currently available;8 most of them are based on
immuno-chromatography strips which perform antigen–antibody
complexation8. However, their sensitivity to malarial parasites is
relatively low (detection limits around 200 iRBC µL−1)5,9. While
these tests are sufﬁcient to diagnose patients with malaria symp-
toms, they are not sensitive enough to identify asymptomatic car-
riers of malaria parasites. To identify these will be a stumbling block
for regions where the disease is targeted for eradication. Moreover,
current MRDTs are unable to quantify parasitemia, which would be
beneﬁcial to monitor treatment efﬁcacy and transmission dynamics.
Further deﬁciencies of MRDTs include cross reactions with anti-
gens of other parasites or intrinsic lack of target antigen in the
parasite population such as the reported deletion of the hrp2 gene,
resulting in false positive or negative results5,10. Moreover, the
antibodies used in the strips do not always perform as expected at
the high and humid temperatures encountered in the regions where
malaria is present8. As typical MRDTs should be kept below
30 °C11, an effective cooling chain must be implemented during
their transport and storage. Alternatively, highly sensitive methods
such as loop-mediated isothermal ampliﬁcation12 or enzyme linked
immunosorbent assay (ELISA)13 are also available, and efforts are
underway to develop quantitative real-time polymerase chain
reaction (qPCRs) for ﬁeld work14–16. However, up to now, none of
these techniques can be used as point of care tests. Few malaria
diagnostic tests are based on the detection of hemozoin, which is a
by-product of hemoglobin digestion by the malaria parasite17,18. It
is a biocrystal which consists of centrosymmetric μ-propionate
dimers of heme (Fig. 1a)19. More importantly, hemozoin is a
powerful biomarker for malaria infection, since it is found in all
erythrocyte stages of all clinically relevant Plasmodium species17,20.
Physical methods such as laser desorption mass spectrometry21,
Raman spectroscopy22, laser-induced nanobubble formation20,
multiple-angle polarization scatter separation23, or magnetically
induced dichroism24–26 have been used to detect hemozoin, also in
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Fig. 1 Biocatalytic precipitation polymerization of NIPAAm as hemozoin assay. a Structure of Hz, a supramolecular crystal of dimers of hematin.
b Schematic depiction of the Hz-catalyzed precipitation polymerization of NIPAAm. c Reaction scheme of the polymerization and photographs of a reaction
mixture at the start of the reaction (left) and after 1 h (right) (1000 ngmL−1 sHz)
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peripheral blood. There are existing efforts to yield these techniques
less complex, showing that hemozoin is a valid biomarker for
malaria diagnosis.
Radical polymerization reactions are ideally suited to amplify
signals in biosensing27–33 because of the creation of one radical at
the site of molecular recognition. This starts a chain reaction that
joins many, often several thousands, monomer molecules of small
molecular weight into a detectable polymer of high molecular
weight. Moreover, if the polymerization is catalyzed by an analyte,
one catalyst molecule initiates and mediates the formation of
many polymer molecules, achieving even stronger molecular
ampliﬁcation. To our knowledge, solubilized hemozoin has not
been explored as a catalyst for radical polymerization, neither for
synthesis purposes nor for biosensing applications, even though
heme-containing enzymes and hemin34–36 are known to initiate
free radical polymerizations37–39 or to catalyze reversible-
deactivation radical polymerizations40–47.
Here, we present an ultrasensitive polymerization-based
assay for the detection and quantiﬁcation of hemozoin.
Solubilized hemozoin is used to catalyze the radical poly-
merization of N-isopropylacrylamide (NIPAAm). The for-
mation of poly(N-isopropylacrylamide) (PNIPAAm) can be
simply detected by conducting the polymerization at 37 °C,
i.e., under conditions in which the polymer precipitates48,49.
This results in a transparent, colorless liquid becoming turbid
(Fig. 1b, c). The formation of turbidity can be visually
observed as an indicator for malarial infection and can be
quantiﬁed by absorbance measurements using simple optical
instruments. Biocatalytic precipitation polymerizations were
carried out under activator regenerated by electron transfer
(ARGET) ATRP conditions, i.e., using an ATRP initiator and
an excess of reducing agent. These conditions were not
selected to achieve reversible-deactivation radical poly-
merizations, but to use stable organic reagents that would not
initiate the polymerization on their own, even when heated or
exposed to sunlight. Moreover, ATRP initiation is a selective
reaction that only speciﬁc biocatalysts such as hemozoin can
achieve, so that interference by other compounds of biological
ﬂuids is low. The assay combines the high sensitivity of signal-
ampliﬁcation by catalytic radical polymerizations with cheap
and stable non-biological reagents and a simple read-out that
does not require sophisticated instrumentation. This renders it
ideal for diagnostics in the ﬁeld, and the assay could become
an important tool in the ﬁght against malaria.
Results
Precipitation polymerizations catalyzed by solubilized Hz.
Natural hemozoin (nHz), which is insoluble under physiological
conditions, was obtained from Plasmodium falciparum cultures.
It was isolated by magnetic afﬁnity chromatography and solubi-
lized in basic conditions (0.4 M NaOH, pH 13.06). As some of the
experiments required larger amounts of hemozoin, synthetic
hemozoin (β-hematin; sHz) was also used. sHz is considered a
chemical and structural analogue to nHz (Fig. 1a)19.
Solubilized Hz can catalyze the polymerization of NIPAAm to
PNIPAAm in the presence of the ATRP reagents sodium
ascorbate (reducing agent) and 2-hydroxyethyl bromoisobutyrate
(HEBIB) (initiator) (Fig. 1b). Polymerizations were carried out as
precipitation polymerizations above the lower critical solution
temperature (LCST) of PNIPAAm48. As the reactions proceeded,
the polymers precipitated and the transparent solution turned
turbid. This process was observable by bare eye (Fig. 1c and
Supplementary Video) and was also monitored by extinction
measurements in a UV–Vis spectrophotometer. Extinction is the
sum of light scattering and absorption, i.e., –log[T], where T is the
transmission at a deﬁned wavelength. After an initial lag phase,
the extinction increased in an almost linear fashion over time
(Fig. 2a). At longer reaction times the rate of turbidity formation
slowed down until the extinction reached a plateau. The rate of
extinction increase was ﬁtted with a straight line and the slope
(ΔE/Δt) was deﬁned as the quantitative read-out of the assay.
A series of experiments was carried out to optimize the
parameters for the assay. Reactions that were carried out in air did
not result in a homogeneous turbidity throughout the solution or
did not polymerize at all (Supplementary Fig. 1), because oxygen
diffused into the reaction mixture and inhibited the polymeriza-
tion. This problem was solved by sealing the reactions from the
atmosphere with a layer of mineral oil. Time-dependent spectral
scans of the polymerization reactions revealed that the increase in
extinction over time, i.e., the response of the assay, was higher in
the UV than in the visible range of the spectrum (Fig. 2a) even
though the monomer and the reducing agent absorb below 400
nm (Supplementary Fig. 2a). This is not surprising, as the increase
in optical density is caused by the increased scattering of light.
However, at high concentrations of hemozoin, the absorption
bands of heme, especially the Soret band around 387 nm, also
contributed to the spectrum (Supplementary Fig. 2b). In order to
minimize this distortion of the assay, extinction measurements
were usually carried out at 600 nm (Fig. 2b, c). At very low Hz
concentrations the absorption of the hemozoin was negligible so
the sensitivity of the assay could be further increased by measuring
extinction at 380 nm (Fig. 2d).
If the hemozoin-catalyzed precipitation polymerization were to
be used as a quantitative assay to determine hemozoin in a solution,
the read-out of the assay should depend on the concentration of
hemozoin. Therefore, precipitation polymerizations were carried
out with various amounts of solubilized Hz (Fig. 2b and
Supplementary Video). A higher concentration of solubilized
hemozoin resulted in a faster increase in extinction, as well as a
shorter lag phase and a higher turbidity at the end of the reaction.
Dose-response curves were obtained by plotting ΔE/Δt against the
concentration of solubilized hemozoin (Fig. 2c). For natural
hemozoin, the read-out of the assay scaled linearly with
the concentration of nHz over a range of ~25–1000 ngmL−1 nHz
(the highest concentration tested) (ΔEΔt ¼ 2:979  105s1
þ4:430  106s1  cassay Hzð Þ; R2= 0.98). At lower concentrations
of the analyte, the signal scaled with the concentration of nHz, but
not linearly. The sensitivity of the assay could be further increased
by conducting the extinction measurements at 380 nm. The assay
read-out at this wavelength increased linearly with the concentra-
tion of nHz at very low amounts of nHz (Fig. 2d). The decision
limit and the detection limit of the assay to determine the presence
of natural hemozoin with a conﬁdence level of 95% were 0.49 ng
mL−1 nHz and 0.85 ngmL−1 nHz, respectively. Based on calcula-
tions given by Newman et al.50 and Egan et al.51, we derived an
equation to determine the level of parasitemia from the measured
concentration of hemozoin (c.f. Supplementary Methods). Accord-
ing to this equation, a concentration of 0.85 ngmL−1 Hz at 380 nm
would hypothetically correspond to a parasitemia of around 1.4
iRBC µL−1 (2.8·10−5%) (1 iRBC µL−1 corresponds to ~0.6 pg µL−1
Hz), showing the potential for the development of a highly sensitive
technique for malaria diagnosis based on Hz-catalyzed precipitation
polymerization.
The dose-response curve for sHz is similar to the one of nHz
(Supplementary Fig. 3), albeit with slightly higher rates of
turbidity formation for any given concentration of the catalyst.
Natural hemozoin contains unsaturated fatty acids52. Most likely,
they reduce the catalytic polymerization activity of the heme
because they are known to scavenge free radicals53.
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The sensitivity of the assay permits the detection and
quantiﬁcation of hemozoin well beyond the limit of UV–vis
spectroscopy, a common method to quantify hemozoin in
solution54. Hz cannot be differentiated by UV–vis spectra from
other compounds at concentrations of <100 ngmL−1, as none of
its characteristic bands can be resolved with certainty (Supple-
mentary Fig. 2). In contrast, the precipitation polymerization assay
gives speciﬁc and clear read-outs at such low concentrations of Hz.
To demonstrate that the assay can also be conducted in a
miniaturized format, hemozoin-catalyzed precipitation polymeriza-
tions were carried out in glass capillaries. After a reaction time of 1h,
the turbidity in the capillaries was more intense with increasing Hz
concentration, while the control reaction without hemozoin
remained transparent (Fig. 3). Thus, the assay can also be carried
out in just a few microliters of reaction volume, which drastically
reduces the required blood sample volume. Moreover, the assay could
be further optimized for use in microﬂuidic lab-on-a-chip devices.
Detection and quantiﬁcation of malaria parasites in blood. To
test the potential of the assay as a diagnostic tool, we mimicked
patient samples by spiking 1 mL full human blood with varying
quantities of non-synchronized P. falciparum-infected iRBCs. As
hemoglobin is known to catalyze biocatalytic ATRP reactions42, it
must be removed from the polymerization test. In a ﬁrst
approach, we isolated the biocrystal by selectively lysing red blood
cells with saponin which disrupted the RBC membranes while
conserving the parasite integrity. This was followed by multiple
centrifugation and washing steps that removed water soluble
molecules. Then, the parasites were lysed and the cell debris
solubilized with SDS, leaving behind the insoluble biocrystals.
The obtained samples were tested with our assay. The rate of
turbidity formation correlates linearly with the concentration of
spiked iRBCs in the blood with a detection limit of 83 iRBCs μL−1
and a decision limit of 45 iRBCs μL−1 (Fig. 4a). Compared to the
theoretical detection limit of the assay based on pure hemozoin
(vide supra), this is ~60 times higher. The loss of sensitivity may
be due to the depletion of hemozoin throughout the multiple
washing steps, or because the calculation of the theoretical
detection limit of parasites includes assumptions on the quantity
of hemozoin per parasite. Control experiments in which blood
samples were not spiked with iRBCs showed comparable tur-
bidity formation rates as the blank reaction. Thus, the sample
preparation quantitively removes all interfering biomolecules,
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Fig. 2 Precipitation polymerizations catalyzed by nHz quantiﬁed by extinction measurements. a Time-dependent UV–vis measurements of a NIPAAm
polymerization catalyzed by 25 ngmL−1 nHz. The spectra were recorded every 30 s. b Time-dependent extinction measurements at 600 nm of NIPAAm
polymerization catalyzed by 10 ngmL−1 (black), 25 ngmL−1 (red), 50 ngmL−1 (blue), 100 ngmL−1 (pink), 150 ngmL−1 (cyan), 400 ngml−1 (navy blue),
and 1000 ngml−1 nHz (violet). A blank reaction without nHz is also observed (purple). c Dose-response curve for nHz at 600 nm. (Average of n= 5 and
SD; the red line represents the linear ﬁt to the data between 25 ngmL−1 and 1000 ngmL−1) d Dose-response curve for low concentrations of nHz at 380
nm (Average of n= 6 and SD; the black line represents the linear ﬁt to the data, the red dotted lines indicate the 95% conﬁdence interval, the orange
vertical line indicates the decision limit and the blue vertical line indicates the detection limit)
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especially hemoglobin, which could catalyze the polymerizations,
leaving hemozoin as the only polymerization active compound
isolated from blood.
While the previous isolation method extracts hemozoin from
blood, a puriﬁcation method that isolates intact malaria parasites
from blood should enhance the sensitivity of the assay, as non-
digested hemoglobin in the parasites together with non-
crystallized heme would also catalyze the polymerizations.
Moreover, this would prevent false positive results caused by
some hemozoin lingering in the blood of a patient after an
infection has been cured55. To test this hypothesis, blood was
spiked with iRBCs, and the erythrocytes of 50 μL samples were
selectively lysed with saponin. The lysis was followed by size
exclusion chromatography using Sepharose as the stationary
phase in hand-driven chromatography cartridges. The isolates
were centrifuged and the resulting pellets, composed of
membrane debris together with parasites, were subjected to the
polymerization tests (Fig. 4b). The read-out of the assay scaled
with the concentration of iRBCs in blood. The detection limit is
9.7 iRBCs μL−1 with a decision limit of 5.3 iRBCs μL−1, i.e., a
greatly improved sensitivity compared to the sample preparation
via isolation of hemozoin. It should be noted that control
reactions without iRBCs showed lower turbidity rate formations
in the model reactions catalyzed by pure hemozoin. This could be
due to the presence of cell membranes that might quench
radicals. In conclusion, the isolation of parasites from blood
allows the precipitation polymerization assay to detect very low
levels of parasitemia in parasite-spiked human blood.
Fundamentals of Hz-catalyzed precipitation polymerizations.
All the hemozoin-catalyzed precipitation polymerizations fol-
lowed the same sequence of events. After a lag phase, the turbidity
increased until it reached a plateau. To gain fundamental
understanding of these three phases, a series of experiments was
conducted (Fig. 5). Turbidity is the direct consequence of sus-
pended particles that scatter light. To characterize the particles
that formed during the reactions, hemozoin-catalyzed poly-
merizations were followed by dynamic light scattering (DLS). The
average diameter of the particles increased linearly to 1100 nm
during the reaction, meaning that more polymer chains
assembled to the particles throughout the experiment (Fig. 5a).
Different concentrations of solubilized hemozoin resulted in
similar particle sizes (Supplementary Fig. 4a). As the rate of
turbidity formation in extinction measurements increased with
the concentration of solubilized hemozoin (Supplementary
Fig. 4b), it can be concluded that higher concentrations of solu-
bilized hemozoin yielded higher numbers of similarly sized
polymer particles.
Although the assay was covered with a layer of mineral oil to
exclude atmospheric oxygen during the reaction, the solutions
were not de-oxygenated to allow for an easy handling of the
reagents. Oxygen in the solution could therefore be responsible
for the lag phase. To test this hypothesis, solutions were purged
with argon prior to the reaction. Turbidity was observed
immediately after the reagents had been mixed (Fig. 5b).
Moreover, ΔE/Δt was slightly higher than in standard assays.
These ﬁndings conﬁrm that oxygen in the aqueous solutions was
the cause of the lag phase. It is possible that oxygen may have
inhibited radical polymerization until it was consumed by the
newly-formed radicals in solution. At the same time, this process
decreased the concentration of the initiator and therefore caused
a slower rate of turbidity formation. While oxygen-free condi-
tions would allow for a more sensitive hemozoin assay,
improvements in reaction rate and shorter assay times are
counterbalanced by a more complex experimental set-up when
working under stringent anaerobic conditions. The assay is
intended to be used in the ﬁeld. As a consequence, we decided to
rely on the in situ consumption of oxygen by the reaction.
The extinction measurements show that the plateau in
turbidity was reached when the reaction stopped. 1H NMR
experiments were performed to measure the conversion in this
phase of the reaction. The monomer to polymer conversion was
<5%, i.e., below the detection limit of NMR spectroscopy, for
reactions catalyzed by 1000 ng mL−1 sHz after a reaction time of
2000 s (Supplementary Fig. 5). To elucidate why the reaction did
not proceed to higher conversions, aliquots of fresh reagents were
added to reactions after they had reached a constant turbidity
(Fig. 5c). Polymerizations could be restarted upon addition of sHz
but did not proceed further when new monomer or reducing
agent were added. Thus, it appears that the catalyst loses its
activity, which may be due to the co-polymerization of the vinyl
groups of the catalyst (two per heme unit) with NIPAAm and
subsequent precipitation of the copolymer chains. To prove this
hypothesis, NIPAAm polymers catalyzed by sHz were synthe-
sized. UV–Vis spectra of puriﬁed polymers show an absorption
band at 387 nm, the Soret band of solubilized hemozoin
(Supplementary Fig. 6). The presence of heme in puriﬁed
polymers was further proven by gel permeation chromatography
(GPC), which showed the polymer peak both in the refractive
index detector and the UV–vis detector (Supplementary Fig. 7).
This is consistent with a previous report that heme can be
copolymerized with vinyl monomers56. Thus, the reaction
resulted in the chemical incorporation of the heme into the
precipitating polymer which removed the catalyst from solution.
Nevertheless, only small quantities of polymers are required for
the formation of turbidity, meaning the assay is highly sensitive to
hemozoin.
Although the reaction was carried out under conditions of
ARGET ATRP, i.e., with an ATRP initiator and a surplus of
reducing agent, we did not expect them to be reversible-
deactivation radical polymerizations, because the reactions were
carried out in a heterogeneous system in which the polymer
chains precipitated throughout the polymerization process. GPC
revealed that a polymer that was synthesized with 1000 ngmL−1
sHz and puriﬁed from reactions after 60 min had a number
average molecular weight of 47000 g mol−1 and a dispersity of
Fig. 3 Hz-catalyzed precipitation polymerization of NIPAAm in glass
capillaries. Microscopic photography (×20 magniﬁcation) of
polymerizations catalyzed by 0 ngmL−1 (left), 400 ngmL−1 (center) and
1000 ngmL−1 (right) sHz after a reaction time of 1 h. The background is a
printed paper
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3.8. These are typical values for a polymer obtained by free radical
polymerization (Supplementary Fig. 7). The only source of
radicals in the reaction mixture was the ATRP initiator, which
suggests that the reaction was initiated by an atom transfer of the
bromine from the initiator to the catalyst.
Temperature stability of assay reagents. If this assay is going to
be used in the ﬁeld, it has to be stable in the hot conditions during
transport and storage in tropical or subtropical countries.
Therefore, we investigated the stability of all reagents in ageing
experiments over a period of 2 months at 50 °C (Supplementary
Figs. 8, 9 and 10). 1H-NMR spectra before and after this extended
exposure to elevated temperatures did not reveal any differences,
i.e., the compounds did not appear to degrade and were stable.
This hints towards a long shelf-life of the assay even at high
temperatures, which represents an important advantage over
current MRDTs or primers for PCR.
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Discussion
Current malaria diagnostics are based on microscopy or PCR,
which are expensive and labor intensive, or depend on MRDTs,
which lack sensitivity for low levels of parasitemia. Thus, alter-
native assays are of high interest. The approach herein uses the
thermo-responsive properties of PNIPAAm in combination with
double signal ampliﬁcation by catalytic radical polymerization to
detect the presence of Hz (solubilized in the assay to heme). Upon
Hz-catalyzed precipitation polymerization of NIPAAm above the
LCST of the polymer, the reaction mixture becomes turbid. This
can be seen qualitatively by unaided eye or recorded quantita-
tively by turbidity measurements. The rate of turbidity formation
scales linearly with the concentration of solubilized hemozoin,
which makes the assay quantitative. The assay can detect as low as
0.85 ng mL−1 Hz in model conditions and could differentiate 10
iRBC μL−1 in parasite-spiked full blood. Though the assay
remains to be studied with various parasite stages, in ﬁeld con-
ditions and with the blood of a variety of patients, the results
indicate that its sensitivity could be up to 20 times higher than
current MRDTs. The assay is suited for resource-limited settings
as it relies on a simple read-out and inexpensive chemicals. The
reagents are also temperature stable, avoiding the necessity for
cool chain storage in the hot environments where malaria is
endemic. However, before the assay can be employed and tested
as a point of care test, further development is required, especially
to engineer a simple-to-use device to extract hemozoin or para-
sites from blood samples. Hemozoin is present throughout the
erythrocyte life cycle of all malaria parasite species including the
sexual gametocyte forms17,20. Thus, it is a pan-species malaria
biomarker. Though identiﬁcation of malaria parasite species is
important for the administration of appropriate treatment
schemes, the assay could be employed to screen populations for
asymptomatic carriers with low levels of parasitemia. The parasite
species would then only have to be conﬁrmed by other methods
for those cases that have been tested positive with the assay.
Therefore, the assay could become a powerful tool in the ﬁght
against malaria. The reactions reported herein represent a bio-
sensing assay based on the precipitation polymerization of a
polymer coupled to turbidity measurements. This sensing prin-
ciple can be applied to detect and quantify other analytes, such as
oxidoreductases and peroxidases, through their highly selective
reaction with alkyl halide initiators. Further efforts will be carried
toward the validation of the biocatalytic hemozoin sensing assay
in clinical settings and toward the implementation of the assay
into a portable instrument format.
Methods
Biocatalytic precipitation polymerization assay. Unless otherwise stated, in a
typical experiment 1.429 g (12.63 mmol) of NIPAAm were weighted together with
250 mg (1.26 mmol) of (+)-sodium L-ascorbate into a round-bottom ﬂask.
Thereafter, 10 mL of sodium phosphate buffer solution (pH 6.5, 0.12M) were
added to obtain a stock solution which was employed for the polymerization
reactions. 0.700 mL of this stock solution were pipetted into disposable semi-micro
poly(methyl methacrylate) cuvettes (path length: 1 cm). Various volumes of solu-
bilized hemozoin solutions in 0.4 M NaOH were added and adjusted to a total
volume of 50 μL of 0.4 M NaOH. The volume of buffer was adjusted to achieve a
total volume of 950 μL in each cuvette with a pH of 6.9. The solutions were then
sealed against ambient oxygen by adding 500 μL of mineral oil. The cuvettes were
incubated for 3 min at 37 °C. Finally, the polymerization was initiated by the
addition of 50 µL of a 375 mM 2-hydroxyethyl HEBIB solution in DMF. The ﬁnal
concentration of reagents in the assay was: 767 mM NIPAAm, 18.7 mM HEBIB
and 76.7 mM sodium ascorbate, i.e., a ratio of 41:1:4.1. The cuvette was placed in a
thermostatted cuvette holder (37 °C) of a UV–vis spectrometer and extinction was
recorded at 600 nm or at 380 nm every 30 s with an integration time of 1 s for up to
4 h.
Data availability
The datasets generated during and analyzed during the current study are available in the
Zenodo repository, DOI 10.5281/zenodo.2541603.
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